Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Lion

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Cancers|September 28, 2021
Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid LeukemiaDiana Campillo-Davo, Sébastien Anguille, Eva Lion
Cells|July 26, 2020
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor ResponsesDiana Campillo-Davo, Donovan Flumens, Eva Lion
Oncoimmunology|March 26, 2013
CD56 marks human dendritic cell subsets with cytotoxic potentialDessie Roothans, Evelien Smits, Eva Lion, et al.
Cytotherapy|June 13, 2012
Dendritic cell vaccination in acute myeloid leukemiaSébastien Anguille, Yannick Willemen, Eva Lion, et al.
Journal for Immunotherapy of Cancer|April 10, 2025
Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive reviewGils Roex, Khloe S Gordon, Eva Lion, et al.
Oncoimmunology|September 26, 2015
Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapyHeleen H Van Acker, Sébastien Anguille, Viggo F Van Tendeloo, et al.
Pharmacology & Therapeutics|November 5, 2016
IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentationJohan Mj Van den Bergh, Eva Lion, Viggo Fi Van Tendeloo, et al.
The Lancet. Oncology|May 30, 2014
Clinical use of dendritic cells for cancer therapySébastien Anguille, Evelien L Smits, Eva Lion, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Strategies to eliminate native T cell receptors for adoptive T cell therapiesDonovan Flumens, Diana Campillo-Davo, Florian Van Oers, et al.
Human Vaccines|March 23, 2011
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answersSébastien Anguille, Eva Lion, Evelien Smits, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Cancers|September 28, 2021
Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid LeukemiaDiana Campillo-Davo, Sébastien Anguille, Eva Lion
Cells|July 26, 2020
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor ResponsesDiana Campillo-Davo, Donovan Flumens, Eva Lion
Oncoimmunology|March 26, 2013
CD56 marks human dendritic cell subsets with cytotoxic potentialDessie Roothans, Evelien Smits, Eva Lion, et al.
Cytotherapy|June 13, 2012
Dendritic cell vaccination in acute myeloid leukemiaSébastien Anguille, Yannick Willemen, Eva Lion, et al.
Journal for Immunotherapy of Cancer|April 10, 2025
Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive reviewGils Roex, Khloe S Gordon, Eva Lion, et al.
Oncoimmunology|September 26, 2015
Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapyHeleen H Van Acker, Sébastien Anguille, Viggo F Van Tendeloo, et al.
Pharmacology & Therapeutics|November 5, 2016
IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentationJohan Mj Van den Bergh, Eva Lion, Viggo Fi Van Tendeloo, et al.
The Lancet. Oncology|May 30, 2014
Clinical use of dendritic cells for cancer therapySébastien Anguille, Evelien L Smits, Eva Lion, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Strategies to eliminate native T cell receptors for adoptive T cell therapiesDonovan Flumens, Diana Campillo-Davo, Florian Van Oers, et al.
Human Vaccines|March 23, 2011
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answersSébastien Anguille, Eva Lion, Evelien Smits, et al.
Pageof 7